Pharma deal value rises 55.2% in July 2026: GlobalData
The healthcare industry reported 87 deals worth $29.5 billion in July 2026, while VC funding stood at $2.3 billion
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Merck expands Singapore lab for biopharma testing
Paolo Carli highlights how the expansion will support analytical and biosafety testing services for Asia Pacific biopharma…
From compliance to circularity: Three ways pharma manufacturers can rethink resource management
Tiyo Kok Fong highlights how pharmaceutical manufacturers can integrate water management, reuse and solvent recovery to strengthen…
Lupin gets US FDA nod for sodium zirconium cyclosilicate
The drug is bioequivalent to AstraZeneca’s Lokelma and indicated for hyperkalaemia in adults
Amneal completes Kashiv BioSciences acquisition
Deal combines Amneal’s commercial scale with Kashiv’s biosimilars research, development and manufacturing capabilities
Zydus launches REVAHALE, India’s first once-daily nebulised LAMA for COPD
REVAHALE (Revefenacin) offers sustained 24-hour bronchodilation through convenient nebulised delivery
Biodeal Pharma raises ₹385 cr growth investment from RMB Capitalworks
Investment validates Biodeal's leadership in specialty pharma manufacturing, strengthens its regulated-market platform, and…
PayU partners with Marg ERP to streamline digital payments for pharma distributors
The partnership integrates PayU’s payment infrastructure with Marg ERP to enable digital collections and automated reconciliation…
The next move on India’s trade chessboard
As tariffs dominate global trade discussions, India's expanding FTA network promises wider market access for Indian pharma. But…
CDSCO to hold quarterly stakeholder meetings to discuss regulatory framework and procedures
Industry welcome the initiative, with industry bodies calling for structured dialogue on regulatory requirements and…